Cns Response Inc 17 Wts

(CNSOW)

By |

Profile

Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company's commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis, and Cell Sheet Engineering.

Contact Information

Website: www.emmausmedical.com
Email: jsherwood@emmauslifesciences.com
Main Phone: +1 310 214-0065
Address: 21250 Hawthorne Boulevard
Address 2: Suite 800
State: CA
City / Town: Torrance
Country: USA
Postal Code: 90503

Issuer Information

Exchange: GREY
CEO: Patrick Herguth
Employees: 21
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

Profile

Emmaus Life Sciences Inc is a biopharmaceutical company engaged in the discovery, development, and commercialization of new treatments and therapies primarily for rare and orphan diseases. The company's commercial product is Endari, an oral pharmaceutical grade L-glutamine treatment indicated to reduce acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Its products in the pipeline include Diverticulosis, and Cell Sheet Engineering.

Contact Information

Website: www.emmausmedical.com
Email: jsherwood@emmauslifesciences.com
Main Phone: +1 310 214-0065
Address: 21250 Hawthorne Boulevard
Address 2: Suite 800
State: CA
City / Town: Torrance
Country: USA
Postal Code: 90503

Issuer Information

Exchange: GREY
CEO: Patrick Herguth
Employees: 21
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange Greys